Deep Vein Thrombosis Mantis

Today, deep vein thrombosis is accepted as a public health problem. After clinical suspicion, color doppler ultrasonography is the first step of the diagnostic process. After the definitive diagnosis has been made, it is necessary to investigate the underlying acquired and genetic factors simultaneously with the treatment.

 

Decreasing the risk of developing pulmonary embolism and postthrombotic syndrome is the main treatment objective. In the treatment of deep vein thrombosis, medical, interventional and surgical modalities are included. Standard heparin, low molecular weight heparin and warfarin are included in the standard treatment protocols.

 

Symptoms are reduced and venous hypertension is regressed with supportive therapies such as the use of varicose veins, occasional elevation of the feet and the support of some veins and the use of blood thinners. These treatment options are intended to reduce complaints, but not to treat a source of illness. With these methods, it is not possible to open the vessel, which has been obstructed for years.

 

Angiography is the opening of vessels using stents and balloons. This treatment is not necessary for every patient. It is usually not applied to patients who have a very mild complaint or who have adapted to live with symptoms of deep vein thrombosis. If there is swelling on the feet every day, if there is pain or walking difficulty, wounds in the leg begin to develop and this deteriorates the patient’s quality of life, the patient is evaluated for this treatment.

 

If deep vein thrombosis is over the femoral vein level and progresses to the abdominal vein, this patient is likely to develop Post-thrombotic syndrome and the patient is a candidate for interventional therapy.

 

This product, called the deep vein thrombosis Mantis, has many advantages for patients.

The battery-powered battery initiates a mechanical rotation of a unique cross-sectional shape with aspirated DVT pharmaco-mechanical deformation and controlled and selective infusion of the fluids indicated by the physician, including peripheral vascular thrombolytic; Double engine volume, low and high speed options and hydrophilic inserts are available. The battery powered hand drive initiates the mechanical rotation of the atraumatic unique cycle shape by aspiration.

 

It protects the vessel wall with its leaf-shaped end design. It also creates vortex effect to prevent distal emboli and thrombus by TPA. The internal infusion port provides TPA and contrast infusion. The tip diameter of the tip diameter can be adjusted from 5 to 20 mm in diameter. Depending on the area of ​​application and vessel size, the physician provides treatment. Significantly reduces the dose of thrombolytic therapy. It significantly prevents post-thrombolytic syndrome and most importantly provides a significant advantage for the patient by reducing hospitalization.



Leave a Reply